Skip to content
Delayed ~15 min

ERAS ERASCA

Health Care · Russell 2000

Next earnings: Wed 11 Nov 2026 · estimated

What 17 analyst firms say about ERASCA: their latest ratings, price targets and how far the stock is from them. How it works

14.41 USD+1.14 (+8.59%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+52.2%to the avg target 21.93 USD+7.52 USD
Buy 11 · Hold 3 · Sell 0

14 rated views · 17 analyst/firm records · 17 firms

Latest report14 Aug 2026avg report date 4 Jun
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8058
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8049

Recent analyst activity · last 90 days

Our tracked history has 6 reports on ERAS from 6 analyst firms in the last 90 days (17 firms in the past year).

Comparing each firm's latest target with its previous one: 2 raised their price target, 1 left it unchanged and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: BofA Securities raised its target from $18.00 (set 14 Jul 2026) to $20.00 on 14 Aug 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Bank of America SecuritiesAlec StranahanHold14 Aug 202620.00 USD
CitigroupUnnamed analystBuy13 Mar 2026—
Clear StreetUnnamed analystBuy6 Mar 202620.00 USD
Clear Street LLCKaveri PohlmanBuy6 Mar 202620.00 USD
Evercore ISIJonathan MillerBuy14 Aug 202624.00 USD
GuggenheimMichael SchmidtBuy13 Aug 202621.00 USD
H.C. WainwrightAndres Y. MaldonadoBuy12 Aug 202622.00 USD
HSBCUnnamed analyst—14 Jul 202620.00 USD
JefferiesMaury RaycroftBuy14 Jul 202624.00 USD
JPMorganAnupam RamaBuy18 Mar 202625.00 USD
MizuhoJoseph CatanzaroBuy12 May 202626.00 USD
Morgan StanleySean LaamanHold20 Jul 202621.00 USD
Piper SandlerKelsey GoodwinBuy11 Aug 202618.00 USD · 13 Mar 2026
StifelLaura PrendergastBuy27 Apr 202630.00 USD
Weiss RatingsUnnamed analyst—8 Sep 2026—
Wolfe ResearchUnnamed analyst—4 Jun 202616.00 USD
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 02:44 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.